Citation Impact
Citing Papers
Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
2008 Standout
Immunomodulatory properties of mesenchymal stromal cells
2007 Standout
Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases
2004 Standout
Peripheral Blood Progenitor Cell Transplantation: Clinical, Practical, and Economic Considerations
1994
Minimal Residual Disease: Detection, Clinical Relevance, and Treatment Strategies
1996
Human Bone Marrow-Derived Mesenchymal (Stromal) Progenitor Cells (MPCs) Cannot Be Recovered from Peripheral Blood Progenitor Cell Collections
1997
The ISHAGE Guidelines for CD34+ Cell Determination by Flow Cytometry
1996 Standout
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
2012 Standout
Clinical significance of proliferative potential of occult metastatic cells in bone marrow of patients with breast cancer
2003
The measurement and therapeutic implications of circulating tumour cells in breast cancer
2005
Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant.
2002
Breast cancer
2019 Standout
Triple-negative breast cancer molecular subtyping and treatment progress
2020 Standout
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Clinical implications of molecular heterogeneity in triple negative breast cancer
2015
Multilineage Cells from Human Adipose Tissue: Implications for Cell-Based Therapies
2001 Standout
The ratio of CD8 + lymphocytes to tumor-infiltrating suppressive FOXP3 + effector regulatory T cells is associated with treatment response in invasive breast cancer
2022 StandoutNobel
Etoposide: four decades of development of a topoisomerase II inhibitor
1998 Standout
Bisphosphonate-associated osteonecrosis of the jaw in breast cancer patients: Recommendations for prevention and treatment
2009
Breast cancer
2016 Standout
The Systemic Amyloidoses
1997 Standout
Bone marrow micrometastases in 109 breast cancer patients: Correlations with clinical and pathological features and prognosis
1997
Minimal Residual Disease in Bone Marrow and Peripheral Blood of Patients with Metastatic Breast Cancer
2003
Cancer Metastasis: Building a Framework
2006 Standout
REVIEW: Detection of circulating breast cancer cells by reverse transcriptase polymerase chain reaction (RT-PCR)
2000
Flowcytometry ‐ Principles and Feasibility in Transfusion Medicine. Enumeration of Epithelial Derived Tumor Cells in Peripheral Blood
1998
Mesenchymal stem cells in health and disease
2008 Standout
Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial
2002 Standout
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
2014
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
2016 Standout
The immune contexture in cancer prognosis and treatment
2017 Standout
Evaluation of breast tumour cell contamination in the bone marrow and leukapheresis collections by RT‐PCR for cytokeratin‐19 mRNA
1998
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
2004 Standout
Isolation of rare circulating tumour cells in cancer patients by microchip technology
2007 StandoutNature
Comparison of idarubicin to daunomycin in a randomized multidrug treatment of childhood acute lymphoblastic leukemia at first bone marrow relapse: A report from the Children's Cancer Group
1996
Significance, detection and markers of disseminated breast cancer cells
2006
Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo
2002 Standout
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Graft-versus-host disease
2009 Standout
PD-L1 (B7-H1) expression and the immune tumor microenvironment in primary and metastatic breast carcinomas
2015
Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment
2011
Botanical polysaccharides: Macrophage immunomodulation and therapeutic potential
2005 Standout
Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells
2004 Standout
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
2016 Standout
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Long-Term Outcome of Patients with Metastatic Breast Cancer Treated with High-Dose Chemotherapy and Transplantation of Purified Autologous Hematopoietic Stem Cells
2011
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study
2008 Standout
RT-PCR determination of maspin and mammaglobin B in peripheral blood of healthy donors and breast cancer patients
2005
Sensitive detection of circulating breast cancer cells by reverse-transcriptase polymerase chain reaction of maspin gene
1996
A Comparative Review of Colony-Stimulating Factors
1997
HLA expression and immunologic propertiesof differentiated and undifferentiated mesenchymal stem cells
2003 Standout
Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation.
1996
A review of autologous hematopoietic cell transplantation
2000 Nobel
Adipose-derived adult stem cells: isolation, characterization, and differentiation potential
2003 Standout
Mobilization of tumour cells during biopsy in an infant with Ewing sarcoma
1996
Monitoring tumour cells in the peripheral blood of small cell lung cancer patients
2002
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Long-term patient survival in ANCA-associated vasculitis
2010 Standout
Clinical significance of tumor-infiltrating lymphocytes in breast cancer
2016
Triple-negative breast cancer—current status and future directions
2009
Molecular Mechanisms of Amyloidosis
2003 Standout
Breast cancer metastasis: markers and models
2005 Standout
Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer
2000
Safe and Effective In Vivo Targeting and Gene Editing in Hematopoietic Stem Cells: Strategies for Accelerating Development
2021 StandoutNobel
Lymphatic Mapping and Sentinel Node Biopsy in the Patient With Breast Cancer
1996 Standout
Carcinoembryonic antigen (CEA)-specific T-cell activation in colon carcinoma induced by anti-CD3 x anti-CEA bispecific diabodies and B7 x anti-CEA bispecific fusion proteins.
1999 StandoutNobel
Human mesenchymal stem cells modulate allogeneic immune cell responses
2004 Standout
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow
2001 Standout
Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: one-year follow-up in five patients
1996
Applications of magnetic nanoparticles in biomedicine
2003 Standout
Optimizing Clinical Benefits of Bisphosphonates in Cancer Patients with Bone Metastases
2010
Heterogeneous proliferative potential of occult metastatic cells in bone marrow of patients with solid epithelial tumors
2002
Genetic and epigenetic aspects of breast cancer progression and therapy.
2014
PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
2015 Standout
Detection and characterization of carcinoma cells in the blood
1998
Detection of Circulating Tumor Cells by Reverse Transcriptase Polymerase Chain Reaction of Maspin in Patients With Breast Cancer Undergoing Conventional-Dose Chemotherapy
2000
Oral Bisphosphonate Use and Breast Cancer Incidence in Postmenopausal Women
2010
Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone
2002 Standout
Rapid Hematopoietic Recovery After Coinfusion of Autologous-Blood Stem Cells and Culture-Expanded Marrow Mesenchymal Stem Cells in Advanced Breast Cancer Patients Receiving High-Dose Chemotherapy
2000 Standout
Detection of Breast Cancer Cells in the Bone Marrow or Peripheral Blood: Methods and Prognostic Significance
2000
Drug Resistance in Cancer: An Overview
2014 Standout
American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update
2014 Standout
Works of NE Davidson being referenced
The effect of zoledronic acid on aromatase inhibitor associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36 months follow-up of ZO-FAST.
2009
OT3-01-06: A Phase 2 Study Investigating the Safety, Efficacy and Surrogate Biomarkers of Response of 5-Azacitidine (5-AZA) and Entinostat (MS-275) in Patients with Advanced Breast Cancer.
2011
Abstract S1-07: Prognostic value of tumor-infiltrating lymphocytes (TILs) in two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199
2013
GRB7-dependent pathways are potential therapeutic targets in triple-negative breast cancer.
2009
Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques [see comments]
1993
Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques [see comments]
1993